Another study reveals that depression correlates with worse clinical outcome in gastric cancer patients, and the in vivo and in vitro experiments disclose that gastric cancer–related depression involves the participation of reactive oxygen species via the ABL1-modulated inflammatory pathway [25]. The gene discussed is ABL1; the disease is depressive symptom measurement.